Reducing Decannulation Time: Limitation of Decannulation Capping Trials (REDECAP)
Study Details
Study Description
Brief Summary
Multicenter randomized trial centered on critically-ill tracheostomized patients, comparing two different decannulation protocols:
-
based on capping trials to decide decannulation,
-
based on the aspiration frequency to decide decannulation time. High-flow conditioned oxygen therapy will be applied to all patients through the tracheal cannula. In patients included in the suctioning frequency based protocol along the study period and in patients included in the capping trial protocol along periods out of capping trials.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
No Intervention: Capping trial protocol Decannulation protocol based on tolerance to 24 hours capping trial to decide when to decannulate. Decapping during the capping trial for aspiration of respiratory secretions is considered a failure criteria of the trial. High flow conditioned oxygen therapy through tracheal cannula will be applied during periods out of capping trials. |
|
Experimental: Suctioning frequency protocol Decannulation protocol based on suctioning frequency to decide when to decannulate (criteria: ≤2 aspirations every 8 h along 24 consecutive hours). Intervention: suctioning frequency of respiratory secretions will be recorded untill fulfill decannulation criteria. Capping trials will not be allowed in this group. High flow conditioned oxygen therapy will be applied through tracheal cannula during all the study period. |
Procedure: Decannulation protocol.
Comparison of two different decannulation protocols: one protocol based on capping trial tolerance to decide when to decannulate vs. protocol based on suctioning frequency of respiratory secretions to decide when to decannulate (criteria: ≤2 aspirations every 8 h along 24 consecutive hours).
Device: High flow conditioned oxygen therapy
High flow conditioned oxygen therapy will be applied during all study period through tracheal cannula in the experimental arm (suctioning frequency based protocol) and during periods out of capping trials in the control arm (capping trials based protocol).
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Decannulation time [Patients will be followed for the duration of hospital stay, an expected average of 3 months]
Time since weaning from mechanical ventilation (24 consecutive hours disconnected) to decannulation
Secondary Outcome Measures
- Decannulation failure [Patients will be followed for the duration of hospital stay, an expected average of 3 months]
Number of patients requiring recannulation during hospital stay / number of patients included in the group X 100
- Intensive Care Unit Lenght of stay [Patients will be followed for the duration of ICU stay, an expected average of 2 months]
Time since ICU admission to ICU discharge
- Hospital lenght of stay [Patients will be followed for the duration of hospital stay, an expected average of 3 months]
Time since hospital admission to hospital discharge
- ICU mortality [Patients will be followed for the duration of ICU stay, an expected average of 2 months]
ICU mortality in every study group
- Hospital mortality [Patients will be followed for the duration of hospital stay, an expected average of 3 months]
Hospital mortality in every study group
- Respiratory infection [Patients will be followed for the duration of hospital stay, an expected average of 3 months]
Post-randomization pneumonia and tracheobronchitis rate in every study group
Eligibility Criteria
Criteria
Inclusion Criteria:
- Critically-ill tracheostomized patients weaned from mechanical ventilation (24 consecutive hours disconnected).
Exclusion Criteria:
- Patients consedered non-decannulable at time of randomization:
-
unconscious patient (motor component of GCS score <6 points).
-
Severe swallowing function (based on drink test).
-
Airway patency problem (based of intolerance of occlusion test).
-
Neuromuscular diseases.
-
Patients with a Sabadell score >2.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Hospital Del Mar | Barcelona | Spain | ||
2 | Hospital Universitario Vall D´Ebron | Barcelona | Spain | ||
3 | Hospital Universitario de Ciudad Real | Ciudad Real | Spain | ||
4 | Hospital Universitario Ramon Y Cajal | Madrid | Spain | ||
5 | Hospital Virgen de La Salud | Toledo | Spain |
Sponsors and Collaborators
- Hospital Virgen de la Salud
Investigators
- Study Chair: GONZALO HERNANDEZ, MD, Hospital Virgen de la Salud
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 3/7/2015 n67